Human Insulin Market Size, Share & Industry Analysis, By Type (Analogue Insulin and Traditional Human Insulin), By Diabetes Type (Diabetes 1 and Diabetes 2), By Distribution Channel (Hospital Pharmacy and Retail & Online Pharmacy), and Regional Forecast, 2024-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 3.1% from 2024-2032

Unit

Value (USD Billion)

Segmentation

By Type

• Analogue Insulin
  • Long-acting
  • Fast-acting
  • Premix
• Traditional Human Insulin
  • Long-acting
  • Short-acting
  • Fast-acting
  • Premix

By Diabetes Type

• Diabetes Type 1
• Diabetes Type 2

By Distribution Channel

• Hospital Pharmacies
• Retail & Online Pharmacies

By Geography

• North America (By Type, By Diabetes Type, By Distribution Channel, and By Country)
  • U.S. (By Diabetes Type)
  • Canada (By Diabetes Type)
• Europe (By Type, By Diabetes Type, By Distribution Channel, and By Country)
  • U.K. (By Diabetes Type)
  • Germany (By Diabetes Type)
  • France (By Diabetes Type)
  • Italy (By Diabetes Type)
  • Spain (By Diabetes Type)
  • Scandinavia (By Diabetes Type)
  • Rest of Europe (By Diabetes Type)
• Asia Pacific (By Type, By Diabetes Type, By Distribution Channel, and By Country)
  • China (By Diabetes Type)
  • Japan (By Diabetes Type)
  • India (By Diabetes Type)
  • Australia (By Diabetes Type)
  • Southeast Asia (By Diabetes Type)
  • Rest of Asia Pacific (By Diabetes Type)
• Latin America (By Type, By Diabetes Type, By Distribution Channel, and By Country)
  • Brazil (By Diabetes Type)
  • Mexico (By Diabetes Type)
  • Rest of Latin America (By Diabetes Type)
• Middle East & Africa (By Type, By Diabetes Type, By Distribution Channel, and By Country)
  • GCC (By Diabetes Type)
  • South Africa (By Diabetes Type)
• Rest of Middle East & Africa (By Diabetes Type)